Sangamo SVP granted 800K stock options
Sangamo Therapeutics reported that SVP and Chief Legal Officer Scott B. Willoughby received a grant of stock options covering 800,000 shares of common stock.
Rhea-AI Filing Summary
Sangamo Therapeutics reported that SVP and Chief Legal Officer Scott B. Willoughby received a grant of stock options covering 800,000 shares of common stock. The options have an exercise price of $0.2601 per share and expire on March 31, 2036.
These options were granted as compensation and do not represent an open-market purchase or sale. One quarter of the options will vest after one year from the grant date, with the remaining shares vesting in 24 equal monthly installments, contingent on his continued service under the company’s 2018 equity incentive plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 800,000 shares
Grant/Award
1 txn
Insider
Willoughby Scott B.
Role
SVP, CHIEF LEGAL OFFICER, SECY
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 800,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 800,000 contracts (Direct)
Footnotes (1)
- F1. One-quarter (1/4) of the shares subject to the option will vest and become exercisable on the first anniversary of the grant date, and the remainder of the shares will vest and become exercisable in 24 successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
Key Figures
Option grant size: 800,000 options
Exercise price: $0.2601 per share
Underlying shares: 800,000 shares
+4 more
7 metrics
Option grant size
800,000 options
Stock Option (Right to Buy) awarded to SVP, CLO
Exercise price
$0.2601 per share
Conversion or exercise price of granted options
Underlying shares
800,000 shares
Common stock underlying the derivative award
Shares after grant
800,000 options
Total derivative securities following transaction
Expiration date
March 31, 2036
Option expiration for this grant
Initial vesting
25% at 1-year anniversary
One quarter vests after first year of grant
Ongoing vesting
24 monthly installments
Remaining options vest monthly after first anniversary
Key Terms
Stock Option (Right to Buy), 2018 EIP, Continuous Service, vest, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
2018 EIP financial
"as provided in the 2018 EIP."
Continuous Service financial
"subject to the Reporting Person's Continuous Service"
vest financial
"the shares subject to the option will vest and become exercisable"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price: 0.2601"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Sangamo Therapeutics (SGMO) report for Scott B. Willoughby?
Sangamo Therapeutics reported that SVP and Chief Legal Officer Scott B. Willoughby received a grant of stock options for 800,000 shares. These options are a compensation award rather than an open-market stock purchase or sale, and give him the right to buy SGMO common shares at a fixed price.
What is the exercise price of the new stock options granted at Sangamo (SGMO)?
The newly granted stock options for Scott B. Willoughby carry an exercise price of $0.2601 per share. This means he can buy SGMO common stock at $0.2601 once the options vest, regardless of the market price at that time.
What is the vesting schedule for the 800,000 Sangamo (SGMO) stock options?
One quarter of the 800,000 stock options will vest and become exercisable on the first anniversary of the grant date. The remaining options then vest in 24 equal monthly installments, conditioned on Scott Willoughby’s continuous service with Sangamo Therapeutics.
When do Scott Willoughby’s Sangamo (SGMO) stock options expire?
The granted stock options held by Scott B. Willoughby expire on March 31, 2036. He must exercise vested options before that expiration date; otherwise, any unexercised options will lapse and no longer provide the right to purchase SGMO shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
